Am J Pathol

1. WU Y, Huang J, Chen H, Tao H, et al
   Tumor-derived oxidative stress triggers ovarian follicle loss in breast cancer.
   Am J Pathol. 2023 Feb 17:S0002-9440(23)00048.
   

   >> Share

   
   

   
   BMC Cancer

2. DAI X, Cai L, Zhang Z, Li J, et al
   SNRPD1 conveys prognostic value on breast cancer survival and is required for anthracycline sensitivity.
   BMC Cancer. 2023;23:376.
   

   >> Share

   
   
3. ZHANG W, Lin S, Zeng B, Chen X, et al
   High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients.
   BMC Cancer. 2023;23:377.
   

   >> Share

   
   
4. AN Y, Fnu G, Xie C, Weber GF, et al
   Meta-analysis of Osteopontin splice variants in cancer.
   BMC Cancer. 2023;23:373.
   

   >> Share

   
   
5. POMEY MP, Nelea MI, Normandin L, Vialaron C, et al
   An exploratory cross-sectional study of the effects of ongoing relationships with accompanying patients on cancer care experience, self-efficacy, and psychological distress.
   BMC Cancer. 2023;23:369.
   

   >> Share

   
   
6. BASSI N, Hovland HN, Rasheed K, Jarhelle E, et al
   Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays.
   BMC Cancer. 2023;23:368.
   

   >> Share

   
   
7. LIU X, Sun K, Yang H, Xia L, et al
   Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study.
   BMC Cancer. 2023;23:361.
   

   >> Share

   
   

   
   Br J Dermatol

8. BAO C, Xu Q, Xiao Z, Wang H, et al
   Abrocitinib as a novel treatment for lichen sclerosus.
   Br J Dermatol. 2023 Apr 24:ljad129. doi: 10.1093.
   

   >> Share

   
   
9. ARENTS BWM
   Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis.
   Br J Dermatol. 2023 Apr 24:ljad068. doi: 10.1093.
   

   >> Share

   
   
10. VALENTI M, Costanzo A
    Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor-patient communication in avoiding drug discontinuation.
    Br J Dermatol. 2023;188:586-590.
    

    >> Share

    
    
11. GAMELL C, Bankovacki A, Scalzo-Inguanti K, Sedgmen B, et al
    CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa.
    Br J Dermatol. 2023;188:636-648.
    

    >> Share

    
    
12. SANTOS LL, Zhu Z, Brown K, Kirby JS, et al
    Initial validation of the Hidradenitis Suppurativa Quality of Life tool in a clinical trial setting.
    Br J Dermatol. 2023;188:672-673.
    

    >> Share

    
    
13. FREW JW
    In search of therapeutic biomarkers to interleukin-23 antagonism in hidradenitis suppurativa.
    Br J Dermatol. 2023;188:588-589.
    

    >> Share

    
    
14. SCHUSTER B, Gallinger J, Philipp-Dormston WG, Vasel M, et al
    Less confident, successful and happy: patients with post-acne hyperpigmentation are stigmatized.
    Br J Dermatol. 2023;188:682-684.
    

    >> Share

    
    
15. WARK KJL, Der Sarkissian SA, Tatian A, Woods J, et al
    The association between pilonidal sinus disease and hidradenitis suppurativa: a systematic review and meta-analysis.
    Br J Dermatol. 2023;188:673-675.
    

    >> Share

    
    
16. MENDES-BASTOS P, Martorell A, Bettoli V, Matos AP, et al
    The use of ultrasound and magnetic resonance imaging in the management of hidradenitis suppurativa: a narrative review.
    Br J Dermatol. 2023;188:591-600.
    

    >> Share

    
    
17. STARRETT GJ, Lee JW, Chatterjee S, Jedrych JJ, et al
    Detection of extensive host-virus DNA hybrids in human polyomavirus 7-associated pruritic rash.
    Br J Dermatol. 2023;188:675-677.
    

    >> Share

    
    
18. DUDINK K, Bouwman K, Chen Y, DePrimo SE, et al
    Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study.
    Br J Dermatol. 2023;188:601-609.
    

    >> Share

    
    
19. WOLK K
    Hope for a new therapy for hidradenitis suppurativa: blocking of granulocyte colony-stimulating factor receptor.
    Br J Dermatol. 2023;188:590.
    

    >> Share

    
    
20. 
    Neutrophil migration in hidradenitis suppurativa.
    Br J Dermatol. 2023;188:e36.
    

    >> Share

    
    

    
    Cancer

21. MANDELBLATT JS, Ruterbusch JJ, Thompson HS, Zhou X, et al
    Association between major discrimination and deficit accumulation in African American cancer survivors: The Detroit Research on Cancer Survivors Study.
    Cancer. 2023;129:1557-1568.
    

    >> Share

    
    
22. HYDE ET, LaCroix AZ, Evenson KR, Howard AG, et al
    Accelerometer-measured physical activity and postmenopausal breast cancer incidence in the Women's Health Accelerometry Collaboration.
    Cancer. 2023 Feb 22. doi: 10.1002/cncr.34699.
    

    >> Share

    
    
23. LU X, He M, Yu L, Gou Z, et al
    Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence?
    Cancer. 2023;129:1492-1501.
    

    >> Share

    
    
24. SPENCER JC, Noel L, Shokar NK, Pignone MP, et al
    Understanding the role of access in Hispanic cancer screening disparities.
    Cancer. 2023;129:1569-1578.
    

    >> Share

    
    
25. GALUS L, Michalak M, Lorenz M, Stoinska-Swiniarek R, et al
    Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD1 therapy.
    Cancer. 2023 Apr 24. doi: 10.1002/cncr.34718.
    

    >> Share

    
    

    
    Cancer Res

26. PARK HR, Shiva A, Cummings P, Kim S, et al
    Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma.
    Cancer Res. 2023 Apr 24:CAN-22-2838. doi: 10.1158/0008-5472.CAN-22-2838.
    

    >> Share

    
    

    
    Clin Exp Dermatol

27. DAS A, Sil A, Kumar P, Khan I, et al
    Blue light and skin: what is the intriguing link?
    Clin Exp Dermatol. 2023 Apr 25:llad150. doi: 10.1093.
    

    >> Share

    
    
28. PEREYRA-RODRIGUEZ JJ, Herranz P, Ruiz-Villaverde R, Elosua-Gonzalez M, et al
    Treatment of severe atopic dermatitis with Tralokinumab in real clinical practice. Short-term effectiveness and safety results.
    Clin Exp Dermatol. 2023 Apr 25:llad153. doi: 10.1093.
    

    >> Share

    
    
29. LOPEZ SANZ P, Guzman Perez M, Guerrero Ramirez C, Manso Cordoba S, et al
    Comment on "Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient" and "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency
    Clin Exp Dermatol. 2023 Apr 25:llad160. doi: 10.1093.
    

    >> Share

    
    
30. KINGSTON P, Yee D, Huang MY, Korouri E, et al
    Shared decision-making and satisfaction with care: a population-based study in acne patients with skin of color in the United States.
    Clin Exp Dermatol. 2023 Apr 25:llad151. doi: 10.1093.
    

    >> Share

    
    

    
    Eur J Dermatol

31. TURCU G, Artenie C, Nowicka D, Arenbergerova M, et al
    Selenium Disulfide-based shampoo applied for 4 weeks significantly improves dandruff and seborrheic dermatitis.
    Eur J Dermatol. 2023;33.
    

    >> Share

    
    
32. MASSIOT P, Reygagne P, Chagnoleau C, Kanoun-Copy L, et al
    Maintenance effect of a once-weekly regimen of a Selenium Disulfide-based shampoo in moderate-to-severe scalp seborrheic dermatitis after initial treatment with topical corticosteroid/salicylic acid.
    Eur J Dermatol. 2023;33.
    

    >> Share

    
    
33. CLAVAUD C, Michelin C, Pourhamidi S, Ziane S, et al
    Selenium disulfide: a key ingredient to rebalance the scalp microbiome and sebum quality in the management of dandruff.
    Eur J Dermatol. 2023;33.
    

    >> Share

    
    

    
    Int J Dermatol

34. DE RE LAI MR, Polo TCF, Miot LDB, Bento GFC, et al
    Gut microbiome diversity and serum levels of lipopolysaccharide-bound protein (LPB) in men with psoriasis under different systemic therapies.
    Int J Dermatol. 2023 Apr 27. doi: 10.1111/ijd.16682.
    

    >> Share

    
    
35. ELIAS ML, Gottesman SP, Sharon VR
    Pigmented basal cell carcinoma of the nipple.
    Int J Dermatol. 2023 Apr 24. doi: 10.1111/ijd.16696.
    

    >> Share

    
    

    
    J Cutan Pathol

36. BAHMAD HF, Oh KS, Alexis J
    Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    J Cutan Pathol. 2023 Apr 27. doi: 10.1111/cup.14438.
    

    >> Share

    
    

    
    J Dermatol

37. YAMAMOTO S, Kuriyama H, Kashiwada-Nakamura K, Kajihara I, et al
    A case of unknown primary melanoma detected with a BRAF gene mutation from a pleural fluid cell block.
    J Dermatol. 2023 Apr 23. doi: 10.1111/1346-8138.16812.
    

    >> Share

    
    

    
    J Invest Dermatol

38. HALLING AS, Fritz BG, Gerner T, Rinnov MR, et al
    Reduced skin microbiome diversity in infancy is associated with increased risk of atopic dermatitis in high-risk children.
    J Invest Dermatol. 2023 Apr 19:S0022-202X(23)01989.
    

    >> Share

    
    
39. MINZAGHI D, Pavel P, Kremslehner C, Gruber F, et al
    Excessive production of hydrogen peroxide in mitochondria contributes to atopic dermatitis.
    J Invest Dermatol. 2023 Apr 19:S0022-202X(23)01987.
    

    >> Share

    
    
40. CHEN CB, Wang CW, Chung WH
    TNF-alpha Blockade Inhibits Matrix Metalloproteinase 9-Mediated Collagenase Activity in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    J Invest Dermatol. 2023 Apr 22:S0022-202X(23)01837.
    

    >> Share

    
    
41. WANG S, Shin DB, Bhutani T, Garshick MS, et al
    Cardiovascular Health in People with Psoriasis: a population-based study in the United States.
    J Invest Dermatol. 2023 Apr 21:S0022-202X(23)01993.
    

    >> Share

    
    
42. TEAGUE HL, Li H, Berg A, Hong C, et al
    The Relationship between Circulating Apolipoprotein A-1 and Atherosclerosis Initiation and Progression in Psoriasis.
    J Invest Dermatol. 2023 Apr 21:S0022-202X(23)01990.
    

    >> Share

    
    
43. CALUGAREANU A, de Masson A, Battistella M, Michel L, et al
    Exploring the non-lymphocytic cutaneous microenvironment in advanced cutaneous T-cell lymphomas using single-cell RNA-sequencing.
    J Invest Dermatol. 2023 Apr 24:S0022-202X(23)01986.
    

    >> Share

    
    

    
    JAAPA

44. MAKOWICZ C
    Skin lesions in a man with end-stage renal disease.
    JAAPA. 2023;36:24-27.
    

    >> Share

    
    

    
    Lancet

45. IQBAL M, Kharfan-Dabaja MA
    Cogent data on allogeneic haematopoietic stem-cell transplantation efficacy in advanced cutaneous T-cell lymphoma.
    Lancet. 2023 Apr 24:S0140-6736(23)00631-1. doi: 10.1016/S0140-6736(23)00631.
    

    >> Share

    
    
46. DE MASSON A, Beylot-Barry M, Ram-Wolff C, Mear JB, et al
    Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
    Lancet. 2023 Apr 24:S0140-6736(23)00329-X. doi: 10.1016/S0140-6736(23)00329.
    

    >> Share

    
    
47. HAKIMI M, North JP, Taylor MA, Hailer A, et al
    Transcriptomics aids differentiation of IL-23 overactivity in a patient with atypical skin and joint disease.
    Lancet. 2023;401:1381.
    

    >> Share

    
    

    
    N Engl J Med

48. NAJJAR SN, Rezigh AB
    Dissecting Cellulitis of the Scalp.
    N Engl J Med. 2023;388:1608.
    

    >> Share

    
    

    
    Nat Rev Cancer

49. CENTENO PP, Pavet V, Marais R
    The journey from melanocytes to melanoma.
    Nat Rev Cancer. 2023 Apr 24. doi: 10.1038/s41568-023-00565.
    

    >> Share

    
    

    
    PLoS One

50. SANCHEZ CARABALLO A, Guzman Y, Sanchez J, Munera M, et al
    Potential contribution of Helicobacter pylori proteins in the pathogenesis of type 1 gastric neuroendocrine tumor and urticaria. In silico approach.
    PLoS One. 2023;18:e0281485.
    

    >> Share

    
    
51. JABLONOWSKA O, Wozniacka A, Szkarlat S, Zebrowska A, et al
    Female genital lichen sclerosus is connected with a higher depression rate, decreased sexual quality of life and diminished work productivity.
    PLoS One. 2023;18:e0284948.
    

    >> Share

    
    
52. WESTERN B, Demmelmaier I, Vistad I, Hansen BH, et al
    How many days of continuous physical activity monitoring reliably represent time in different intensities in cancer survivors.
    PLoS One. 2023;18:e0284881.
    

    >> Share

    
    
53. BO MC, Merlo A, Ligabue MB, Bassi MC, et al
    Self-managed physical activity in breast cancer survivors: A scoping review.
    PLoS One. 2023;18:e0284807.
    

    >> Share

    
    
54. TWEEDALE B, Collier F, Waidyatillake NT, Athan E, et al
    Mycobacterium ulcerans culture results according to duration of prior antibiotic treatment: A cohort study.
    PLoS One. 2023;18:e0284201.
    

    >> Share

    
    
55. PRUGSAKIJ W, Numsawat S, Netchareonsirisuk P, Tengamnuay P, et al
    Mechanistic synergy of hair growth promotion by the Avicennia marina extract and its active constituent (avicequinone C) in dermal papilla cells isolated from androgenic alopecia patients.
    PLoS One. 2023;18:e0284853.
    

    >> Share

    
    
56. CARBONARA CEM, Roza NAV, Quadros KRS, Franca RA, et al
    Effect of aluminum accumulation on bone and cardiovascular risk in the current era.
    PLoS One. 2023;18:e0284123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share